Stuart C. Apfel

Albert Einstein College of Medicine — United States

Neuroscience · Life Sciences

26h-index3.8kcitations53works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nerve injury and regeneration(23), Pain Mechanisms and Treatments(19), Botulinum Toxin and Related Neurological Disorders(12), Cancer Treatment and Pharmacology(11), Neurogenesis and neuroplasticity mechanisms(5)

Publications53 total

Effects of Alcohol Administered with Flibanserin in Healthy Premenopausal Women: A Randomized, Double-Blind, Single-Dose Crossover Study
The Journal of Sexual Medicine·2019· 13 citedOpen Access
033 Effects of Alcohol Administered with Flibanserin in Healthy Premenopausal Women: A Randomized, Double-Blind, Single Dose, Seven-Way Crossover Study
The Journal of Sexual Medicine·2019
SUN-345 Safety Analysis of High-Specific-Activity I-131 MIBG (AZEDRA®) in Patients with Iobenguane Scan Positive Cancers
Journal of the Endocrine Society·2019· 2 citedOpen Access
139 Effects of Alcohol Administered With Flibanserin in Healthy Premenopausal Women: A Randomized, Double-Blind, Single-Dose, Seven-Way Crossover Study
The Journal of Sexual Medicine·2019· 1 cited
Pooled safety analysis of high-specific-activity I-131 MIBG in iobenguane scan positive cancer patients.
Journal of Clinical Oncology·2019
Efficacy and Safety of High-Specific-Activity <sup>131</sup>I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma
Journal of Nuclear Medicine·2018· 272 citedOpen Access
Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with Hypoactive Sexual Desire Disorder: A <i>Post Hoc</i> Analysis
Journal of Women s Health·2017· 9 citedOpen Access
226 Effect of Flibanserin on Body Weight During Treatment for Hypoactive Sexual Desire Disorder in Premenopausal and Postmenopausal Women
The Journal of Sexual Medicine·2017
MP47-14 SELF-REPORTED ALCOHOL USE AND HYPOTENSION-AND-SYNCOPE-RELATED ADVERSE EVENTS IN FLIBANSERIN-TREATED PREMENOPAUSAL WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER
The Journal of Urology·2016Open Access
557 Generation of microRNA-sensitive VSV vectors to reduce neurotoxic side effects
European Journal of Cancer Supplements·2010
Generation of microRNA-Sensitive VSV Vectors for Safer Treatment of Hepatocellular Carcinoma and Hepatic Metastasis of Colorectal Cancer
Max Planck Institute for Plasma Physics·2010
Botulinum toxin for neuropathic pain?
Neurology·2009· 8 cited
Neurotrophic Factors in the Treatment of Peripheral Neuropathy
Novartis Foundation symposium·2007· 37 cited
Diabetic neuropathy models: Are they relevant?
Drug Discovery Today Disease Models·2006· 6 cited
(752)
Journal of Pain·2006· 3 citedOpen Access
The Healthy Body Handbook: A Total Guide to the Prevention and Treatment of Sports Injuries
2004· 1 cited
Thalidomide neuropathy
Neurology·2004· 26 cited
Nerve growth factor for the treatment of diabetic neuropathy: What went wrong, what went right, and what does the future hold?
International review of neurobiology·2002· 299 cited
Is the therapeutic application of neurotrophic factors dead?
Annals of Neurology·2001· 44 citedOpen Access
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials
Journal of the Neurological Sciences·2001· 106 cited
page 1 of 3Next →

Frequent Co-authors

John A. Kessler(15), Joseph C. Arezzo(6), Bruce T. Adornato(3), William J. Litchy(3), James A. Simon(3), Anita H. Clayton(3), Hinrich Staecker(3), David C. Saidoff(3), Marc Rendell(2), Richard B. Lipton(2), Herbert H. Schaumburg(2), Charles A. Sanders(2), C. A. Rask(2), Daniel A. Pryma(2), Bennett B. Chin(2), Miguel Hernandez Pampaloni(2), Jessica Jensen(2), Tess Lin(2), Theresa White(2), Nancy Stambler(2)